A monoclonal antibody driven biodiagnostic system for the quantitative screening of breast cancer

Biotechnology Letters

Volumn 26, Issue 17, 2004, Pages 1335-1339

  Pulido Cejudo, Gabriel ^a   Miranda, Hernando ^b   El Abdaimi, Khadija ^a   Wang, Chen ^a   Kar, Bratati ^a   Acevedo, Jorge Medina ^c   Cárdenas, José Manuel ^c   Gutiérrez, Elsa Sarti ^d,e   Palacios, Gregorio Pérez ^b  

^a Canbreal Therodiagnostics International Inc   (Canada)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c ICT SA de CV   (Mexico)

^d Grupo Columbia SA de CV Ejidos de Santa Ursula Coapa   (Mexico)

^e Secretary of Health of Mexico   (Mexico)

Author keywords

Biodiagnostics; Blood test; Breast cancer; Monoclonal antibodies; Quantitative screening

Indexed keywords

BIODIAGNOSTICS; BLOOD TESTS; BREAST CANCER; QUANTITATIVE SCREENING;

BIOTECHNOLOGY; BLOOD; COST EFFECTIVENESS; ENZYME KINETICS; ENZYMES; MONOCLONAL ANTIBODIES; SCREENING; TUMORS;

ONCOLOGY;

CYTOSOL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; MULTIENZYME COMPLEX; NUCLEOSIDE DIPHOSPHATE KINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BREAST TUMOR; COST; ECONOMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; COSTS AND COST ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; LEUCYL AMINOPEPTIDASE; MASS SCREENING; MIDDLE AGED; MULTIENZYME COMPLEXES; NUCLEOSIDE-DIPHOSPHATE KINASE; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 21644470693     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1023/B:BILE.0000045629.57791.5a     Document Type: Article

References (18)

1. Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the million women study. Lancet 362: 419-427.
2. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin. Chem. 49: 1-6.
3. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 289: 3243-3253.
4. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. N. Engl. J. Med. 338: 1089-1096.
5. Fletcher SW, Elmore JG (2003) Mammographic screening for breast cancer. N. Engl. J. Med. 348: 1672-1680.
6. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J. Bioenerg. Biomembr. 32: 247-258.
7. Larkin M (2001) Breast self examination does more harm than good, says task force. Lancet 357: 2109.
8. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279: 915-921.
9. Parkin M (2001) Global cancer statistics in the year 2000. Lancet Oncol. 2: 533-542.
10. Pulido-Cejudo G (1994) Monoclonal antibodies directed against NDP-Kinase. Canadian Patent 2,108,533, Ministry of Health Canada.
11. Pulido-Cejudo G (2001) A monoclonal antibody against estrogen stimulated leucine aminopeptidase. Canadian Patent 2,303,505, Ministry of Health Canada.
12. Pulido-Cejudo G (2003) Tandem immnuo-assay for cancer. US Patent 6,521,415 B1, Ministry of Health Canada.
13. Pulido-Cejudo G, Gagnon J, Leclerc JM, Jamison K, Gordon J, Campione-Piccardo J (1994) Measurement of nucleoside diphosphate kinase-Nm23 activity by anion-exchange high-performance liquid chromatography. J. Chromatogr. B, Biomed. Appl. 660: 37-47.
14. Pulido-Cejudo G, Jamison K, Alderdice S, Burke K, Pulido A (1999) Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards HIV infection. In: Skouteris GG, Nicolson GL, eds. Intermolecular Cross-Talk in Tumour Metastasis. Vol. 311, 1st edn. Amsterdam: IOS Press, pp. 123-136.
15. Roymans D, Willems R, Van Blockstaele DR, Slegers H (2002) Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with the multiple partners: possible consequences in tumour metastasis. Clin. Exp. Metastasis 19: 465-476.
16. Shekhar PVM, Werdel J, Basrur VS (1997) Environmental estrogen stimulation of growth and estrogen receptor function in preneo-plastic and cancerous human breast cell lines. J. Natl. Cancer Inst. 89: 1774-1782.
17. Wassertheil-Smoller S (2004) Biostatistics and Epidemiology, 3rd edn. New York: Springer.
18. Wooster R, Bignell G, Lancaster JM, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792.